NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Announces Recommendation of MammaPrint in Germanyโs AGO Guidelines, at St. Gallen International Breast Cancer Conference
Company Also Highlights FDA Clearance of MammaPrint in FFPE IRVINE, CA and AMSTERDAM, THE NETHERLANDS โ Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Read More
Agendiaโs BluePrint Molecular Subtyping Assay Highlighted at the 32nd Annual Miami Breast Cancer Conference
Results of the NBRST Trial Using Agendiaโs BluePrint 80-Gene Molecular Subtyping Assay Presented IRVINE, CA and AMSTERDAM, THE NETHERLANDS โ Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, said new Read More
Agendia Receives New FDA Clearance for MammaPrint FFPE Breast Cancer Test
FDA Decision Covers Use of MammaPrint in FFPE for theย 70-Gene Breast Cancer Recurrence Assay IRVINE, CA and AMSTERDAM, THE NETHERLANDS โ Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced Read More